T1	Chemical	15 56	Gefitinib in combination with bevacizumab
T2	Disease	159 169	NSCLC with
T3	Limited_variation	181 213	EGFR gene mutations , especially
T4	Limited_variation	230 267	exon 19 deletion mutations , although
R1	treats	Arg1:T1	Arg2:T2
R2	treats	Arg1:T1	Arg2:T4
R3	influences	Arg1:T2	Arg2:T1
R4	isAssociatedWith	Arg1:T2	Arg2:T4
R5	influences	Arg1:T3	Arg2:T1
R6	influences	Arg1:T4	Arg2:T1
R7	treats	Arg1:T4	Arg2:T2
